Explore more publications!

Press Releases

Atos positioned as a Leader in the IDC MarketScape™: Middle East Managed Detection and Response (MDR) 2025 Vendor Assessment
Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates
Everyday movements are more beneficial for osteoarthritis patients than handgrip strength
Dragonpass Unveils the Loyalty Index, Redefining What Loyalty Means for Today’s Consumers
AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai
Syrian Leader Visits Russia for Second Round in Four Months

Syrian Leader Visits Russia for Second Round in Four Months

Israeli Forces Kill Palestinian in Gaza

Israeli Forces Kill Palestinian in Gaza

Next Generation Sequencing (NGS) Market to Reach US$33.3 Bn by 2032 | Persistence Market Research
Medsynaptic to Showcase latest version of AI Enabled Medsynapse RIS-PACS and Imaging Solutions at WHX 2026, Dubai
Blue Goat Cyber to Serve as Title Sponsor at MedTech World Middle East 2026 in Dubai, February 11-13
Hyperspectral Imaging Market Booming with Rapid Growth Through 2033  | Headwall Photonics, SPECIM, Teledyne Technologies
Propertize Ventures Appoints Khawar Malik as Middle East Capital Advisor to Lead $1 Billion Sports-Anchored Real Estate Capital Initiative
NurExone Appoints Eyal Gabbai to Board, Adding Large-Scale Healthcare System and Capital Markets Expertise
Healthcare Mobility Solutions Market Accelerates at 20.44% CAGR, Targeting USD 1.05 Trillion by 2034
GymNation's 2026 Survey Reveals What's Really Driving Middle East Fitness Growth
Shandong Xiangying New Materials Advanced Solutions Pvc Marble Wall Panels Manufacturer
Saudi Arabia’s Milaf Brand Accelerates Global Expansion as Kurida F.Z.E. Scales Beverage Portfolio Across Eurasia
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of 2mg/kg Body Weight Every-Four-Weeks for Elfabrio® (pegunigalsidase alfa) ▼ in the EU
Lakefront Advisory Sàrl Announces USD 55M Strategic Investment in St. Regis Private Villas & Residences, Abu Dhabi

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions